Repositorio digital RUNA

    • Español
    • Galego
    • English
  • Español 
    • Español
    • Galego
    • English
  • Login
RUNABibliosaúdeXunta de galicia. Consellería de sanidadeServicio Galego de saúde
  • REPOSITORIO
  • SOBRE NOSOTROS
    • Sobre RUNA
    • Normativa
    • Política Sergas
  • AYUDA
    • Ayuda
    • FAQ
  •   RUNA Principal
  • Navegar por autor
JavaScript is disabled for your browser. Some features of this site may not work without it.

Navegar por autor "Pérez Encinas, Manuel Mateo"

  • 0-9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Ordenar por:

Orden:

Resultados:

Mostrando ítems 1-20 de 24

  • título
  • fecha de publicación
  • fecha de envío
  • ascendente
  • descendente
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
    • Thumbnail

      A good adherence to ELN 09 recommendations in chronic myeloid leukemia (CML) treatment with imatinib, is associated with better outcomes in patients treated outside clinical trials 

      2012- Pérez Encinas, Manuel Mateo
      Ver Item
    • Thumbnail

      A prognostic index for patients with refractory or in first relapsed acute myeloid leukemia treated with FLAG-IDA or flago-IDA 

      2014- Pérez Encinas, Manuel Mateo
      Ver Item
    • Thumbnail

      ACUTE MYELOID LEUKEMIA IN PATIENTS 70 AND ABOVE. AZACITIDINE VERSUS INTENSIVE CHEMOTHERAPY 

      2014- Debén Ariznavarreta, Guillermo; Pérez Encinas, Manuel Mateo
      Ver Item
    • Thumbnail

      The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution 

      2019- MOSQUERA ORGUEIRA, ADRIAN; Antelo Rodríguez, Beatriz; Alonso Vence, Natalia; Díaz Arias, José; Díaz Varela, Nicolás; [et al.]
      Ver Item
    • Thumbnail

      Azacitidine as front-line therapy in AML: Results from spanish national registry. Alma study investigators 

      2012- Debén Ariznavarreta, Guillermo; Pérez Encinas, Manuel Mateo
      Ver Item
    • Thumbnail

      Azacitidine frontline therapy for unfit acute myeloid leukemia patients: clinical use and outcome prediction 

      2015- Debén Ariznavarreta, Guillermo; Pérez Encinas, Manuel Mateo
      Ver Item
    • Thumbnail

      Azacitidine in older patients with acute myeloid leukemia (AML). Results from the ALMA study according to the MRC risk index score 

      2015- Debén Ariznavarreta, Guillermo; Pérez Encinas, Manuel Mateo
      Ver Item
    • Thumbnail

      Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens. 

      2011- Pérez Encinas, Manuel Mateo
      Ver Item
    • Thumbnail

      Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor? 

      2014- Pérez Encinas, Manuel Mateo
      Ver Item
    • Thumbnail

      DO CHRONIC MYELOID LEUKEMIA PATIENTS WITH LATE "WARNING" RESPONSES BENEFIT FROM SWITCHING THERAPY TO A SECOND GENERATION TYROSINE KINASE INHIBITOR? 

      2014- Pérez Encinas, Manuel Mateo
      Ver Item
    • Thumbnail

      Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling 

      2020- MOSQUERA ORGUEIRA, ADRIAN; Díaz Arias, José; Cid López, Miguel; Peleteiro Raindo, Andrés; Antelo Rodríguez, Beatriz; [et al.]
      Ver Item
    • Thumbnail

      Intensive (2+5) or semi-intensive (FLUGA) chemotherapy for patients with acute myeloid leukemia who are 70 years of age or older 

      2013- Pérez Encinas, Manuel Mateo
      Ver Item
    • Thumbnail

      LIF, a novel STAT5-regulated gene, is aberrantly expressed in myeloproliferative neoplasms. 

      2011- Pérez Encinas, Manuel Mateo; Quinteiro García, Celsa
      Ver Item
    • Thumbnail

      MANAGEMENT OF RENAL IMPAIRMENT IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: PRELIMINARY DATA OF A LARGE OBSERVATIONAL, PROSPECTIVE STUDY 

      2014- Pérez Encinas, Manuel Mateo
      Ver Item
    • Thumbnail

      Oral anticoagulant therapy for the prevention of recurrent thrombosis in patients with polycythemia vera or essential thrombocythemia 

      2015- Pérez Encinas, Manuel Mateo
      Ver Item
    • Thumbnail

      Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia 

      2015- Pérez Encinas, Manuel Mateo
      Ver Item
    • Thumbnail

      Outcomes of chronic myeloid leukemia (CML) patients who stopped second generation tyrosine kinase inhibitors (2GTKIS) as second line treatment. results of the CML Spanish National Registry (RELMC) 

      2012- Pérez Encinas, Manuel Mateo
      Ver Item
    • Thumbnail

      Renal Response in Patients (Pts) With Relapsed Refractory Multiple Myeloma (RRMM) and severe renal impairment (RI): Interim data from a large observational, prospective study 

      2015- Pérez Encinas, Manuel Mateo
      Ver Item
    • Thumbnail

      Renal response in patients (PTS) with relapsed refractory multiple myeloma (RRMM): Interim data of a large observational, prospective study 

      2014- Pérez Encinas, Manuel Mateo
      Ver Item
    • Thumbnail

      Retrospective study of azacitidine in patients of advanced age with acute myeloid leukemia (lma). Results of the alma/ pethema cohort in comparison with the mrc risk index score 

      2015- Debén Ariznavarreta, Guillermo; Pérez Encinas, Manuel Mateo
      Ver Item

      Navega

      Todo RUNAColeccionesCentrosAutoresTítulosDeCSMeSHCIETipos de contenidos

      DE INTERÉS

      Sobre Acceso AbiertoDerechos de autor
      TwitterRSS
      Xunta de Galicia
      © Xunta de Galicia. Información mantida e publicada na internet pola Consellería de Sanidade o Servizo Galego de Saúde
      Aviso legal | RSS
      Galicia